8/3/2023 0 Comments Tessera therapeuticsTessera Therapeutics is pioneering Gene Writing™, which consists of multiple technology platforms designed to offer scientists and clinicians the ability to write therapeutic messages into the human genome, thereby potentially curing diseases at their source. Title: LNP-AAV Hybrid Delivery of a DNA Gene Writer System Corrects Severe Ornithine Transcarbamylase Deficiency in Neonatal Mice and Improves AAV Potency in Adult Mouse and NHP Liversĭate and Time: May 19, 2023, 12:00 p.m.Session: Hematologic and Immunologic Diseasesĭate and Time: May 18, 2023, 5:15 p.m. Title: Highly Efficient Correction of the Sickle Cell Disease Mutation in Patient HSC Using an RNA Gene Writing System, an RNA-based, Nuclease-Free Approach to Genome Editing.Session: Gene Targeting and Gene Correction: New Technologiesĭate and Time: May 18, 2023, 4:30 p.m. Title: Writing a Chimeric Antigen Receptor (CAR) into T cell Genomes Using RNA-based Gene Writing Systems.Session: Gene Targeting and Gene Correction: Liverĭate and Time: May 18, 2023, 2:15 p.m. Title: RNA Gene Writers Drive Therapeutically Relevant Levels of Correction of the PAH Gene Responsible for Phenylketonuria in Mouse and Non-Human Primate Models.Session: Expanding the Genome Editor Toolbox and Translation Toward the Clinicĭate and Time: May 19, 2023, 8:50 a.m. Title: Writing DNA with RNA: Genome Engineering by Target Primed Reverse Transcription.In addition, Tessera’s Senior Vice President, Head of Platform, Cecilia Cotta-Ramusino, Ph.D., will give an invited presentation on the Company’s Gene Writing and delivery technologies as part of a scientific symposium titled “Expanding the Genome Editor Toolbox and Translation Towards the Clinic”.ĭetails of the Company’s ASGCT 26 th Annual Meeting presentations are as follows: SOMERVILLE, Mass., (GLOBE NEWSWIRE) - Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced that it will present new preclinical data at the upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting taking place in Los Angeles, California, May 16 – 20, 2023.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |